Two new glycosides of 30-normedicagenic acid, namely 3-O-[β-D-glucuronopyranosyl methyl ester]-2β,3β-dihydroxy-30-noroleane-12,20(29)-diene-23,28dioic acid 28-O-β-D-glucopyranosyl ester, and 3-O-β-D-glucopyranosyl-2β,3β-dihydroxy-30-noroleane-12,20(29)-diene-23,28-dioic acid, together with the known 3-O-β-glucopyranosyl-2β,3β-dihydroxy-30-noroleane-12,20(29)-diene-23,28-dioic acid 28-O-β-glucopyranosyl ester, and 3-O-β-glucuronopyranosyl-2β,3β-dihydroxy-30-noroleane-12,20(29)-diene-23,28-dioic acid 28-O-β-glucopyranosyl ester were isolated from the aerial parts of Chenopodium foliosum Asch. The structures of the compounds were determined by means of spectroscopic methods (1D and 2D NMR, UV, IR) and HRMS-ESI. The compounds were tested for cytotoxicity on three leukemic cell lines (BV-173, SKW-3, HL-60). In addition, the saponins showed moderate stimulatory effects on interleukin-2 production in PHA/PMA stimulated Jurkat E6.1 cells.
The genus Chenopodium {subfamily Chenopodioideae; family Amaranthaceae (Caryophyllales)} [1] has been estimated to comprise some 150 species [2] . Chenopodium spp. have been used as leafy vegetables and important subsidiary grain crops for human and animal foodstuff [3] . Diverse species of this genus have been employed as medicinal agents in traditional systems of medicine [4] . C. foliosum Asch, known as "garliche" or "svinski yagodi" (swine's berries), has been recognized by Bulgarian legislation as a medicinal plant. Interviews with local people revealed that infusions of the aerial parts have been used for treatment of cancers, tuberculosis and abscesses [unpublished data] . Phytochemical investigations of the aerial parts of this plant showed the presence of terpenes, in the essential oil [5] , as well as flavonol glycosides [6a] . The aim of the present study was to isolate and identify the main saponins, as well as to evaluate their cytotoxic effects and their ability to modulate IL-2 production in Jurkat T-cells.
Extensive chromatographic separation of the methanolic extract led to the isolation of two new compounds (3 and 4), as well as two known glycosides of 30-normedicagenic acid (1 and 2) . The signals in the 1 H and 13 C NMR spectra were unambiguously assigned using 2D NMR techniques. The structure of 1 was established as 3-O-βglucopyranosyl-2β,3β-dihydroxy-30-noroleane-12,20(29)-diene-23, 28-dioic acid 28-O-β-glucopyranosyl ester, while the structure of 2 was determined as 3-O-β-glucuronopyranosyl-2β,3β-dihydroxy-30noroleane-12,20(29)-diene-23,28-dioic acid 28-O-β-glucopyranosyl ester (Figure 1 Detailed analysis of the NMR spectra pointed out 2β,3β-dihydroxy-30-noroleanane-12,20(29)-diene-23,28-dioic acid (30-normedicagenic acid) as aglycone [7] . In addition, the 1 H NMR spectrum showed two anomeric sugar proton signals at δ H 4.29 (7.6 Hz) and 5.20 (8.2 Hz) indicating a β-orientation of the glycosidic linkage. The former signal gave a cross-peak with C-3 (δ C 82.4) of the aglycone, while the latter correlated with the signal of C-28 (δ C 174.6). The remaining proton signals of the glucose resonated between δ H 3.05 to 3.67 ppm. The 1 H NMR spectrum of 3 showed also a singlet integrating for three protons at δ H 3.66 that correlated in the HMBC spectrum with C-6' of the glucuronic acid moiety. Thus, the structure of 3 was identified as 3-O-[β-D-glucuronopyranosyl methyl ester]-2β,3β-dihydroxy-30-noroleane-12,20(29)diene-23,28-dioic acid 28-O-β-D-glucopyranosyl ester. It could hypothesized that compound 3 might be an artifact of 2 due to extraction of the plant material with methanol. In order to confirm or reject this hypothesis compound 2 was dissolved in methanol, the mixture heated under reflux for 4 h, then left for one week. TLC and HPLC-UV analysis of the mixture did not show detectable traces of 3. fraction of the hydrolyzate. The 1 H-and 13 C-NMR spectra ( Table 1 and 2) clearly pointed out 30-normedicagenic acid as the aglycone of 4. The 1 H NMR spectrum showed only one anomeric sugar proton signal located at δ H 4.20 that appeared as a doublet with a coupling constant of J=7.7 Hz, suggesting a β-orientation of the glycosidic linkage. This doublet gave a cross-peak with the signal at δ C 82.9, which was assigned to C-3. Thus, the structure of 4 was identified as 3-O-β-D-glucopyranosyl-2β,3β-dihydroxy-30noroleane-12,20(29)-diene-23,28-dioic acid. 30-Normedicagenic acid glycosides have been rarely found in nature, with only six having been isolated up to now, four from Amarathus caudatus [6b,7] ; one from A. cruentus [6c] and one from Lindernia pyxidaria (Scrophulariaceae) [8] .
The cytotoxicity of compounds 1-4 was evaluated in a panel of human tumor cell lines after 72 h exposure. The IC 50 values are presented in Table 3 . In general, the compounds exhibited only marginal activity, with the exception of 3, which decreased the cellular viability at lower concentrations in SKW-3 cells. Moreover, we determined whether compounds 1-4 intervene in the mitogeninduced production of IL-2 in Jurkat E6-1 (model of human T-cell) when applied at the non-toxic concentration of 25 μM. As evident from the results summarized in Table 4 , the tested saponins exhibited moderate stimulatory effects on the PHA/PMA-triggered release of IL-2 in Jurkat E6-1 cells. Interleukin-2 is a lymphokine Triterpene saponins from Chenopodium foliosumm Natural Product Communications Vol. 7 (11) 2012 1421 with a well-appreciated role in the immune system. It stimulates clonal expansion, proliferation and differentiation of native T-cells, activates the T-cells and natural killer-mediated cytotoxicity, and thus is involved in immune responses [9]. 30-noroleane-12,20(29)-diene-23,28-dioic acid 28-O-β 4 , flow rate 1 mL/min, UV detection at 250 nm]. The chromatogram showed a peak at 18.7 min, which coincided with the t R value of the tolylthiocarbamoyl-thiazolidine derivative of D-glucose. The derivative synthesized from L-glucose was detected at 17.1 min. The methanol fraction was dissolved in 1 mL water and 50000 units of β-glucuronidase were added. The mixture was left for 48 h at room temperature then was filtered through Diaion HP-20SS, followed by subsequent elution with H 2 O and MeOH. The water portion was evaporated to dryness and analyzed for sugars by HPLC. The occurrence of D-glucuronic acid (t R value of the tolylthiocarbamoyl-thiazolidine derivative was 19.6 min) was found in the residue.
3-O-[β-D-Glucuronopyranosyl methyl ester]-2β,3β-dihydroxy-
Acid hydrolysis of 4: Compound 4 (2 mg) was refluxed with 2 mL of a mixture of 2N HCl-MeOH (1:1) for 2 h. The reaction mixture was evaporated to dryness, dissolved in 3 mL water and extracted with EtOAc (3×5 mL). HPLC analysis of the water layer identified D-glucose as a sugar moiety.
Cytotoxicity assay:
The cell lines HL-60 (acute myeloid leukemia), BV-173 (chronic myeloid leukemia), and SKW-3 (T-cell leukemia) were purchased form DSMZ (Germany), and Jurkat E6-1 (clone of the Jurkat-FHCRC cell line, a derivative of the Jurkat T-cell leukemia cell line) was supplied by ATCC (USA). Cells were cultured routinely in a controlled environment: 37°C in a 5% CO 2 humidified atmosphere and were maintained in RPMI-1640 medium, supplemented with 2 mM L-glutamine and 10% fetal calf serum. The cellular viability was assessed using the MTT-dye reduction assay, as described by Mosmann, with slight modifications [10b,c]. In brief, exponentially proliferating cells were seeded in 96-well flat-bottomed microplates (100 μL/well) at a density of 10 5 cells per mL and after 24 h incubation at 37°C they were exposed to various concentrations of the tested compounds for 72 h. For each concentration, a set of at least 8 wells was used in parallel. After the treatment period, 10 μL MTT solution (10 mg/mL in PBS) aliquots were added to each well. Thereafter, the microplates were incubated for 4 h at 37°C and the MTT-formazan crystals formed were dissolved by addition of 100 μL/well 5% formic acid solution in 2-propanol. The MTT-formazan absorption was measured using a Beckman-Coulter DTX800 multimode microplate reader at 580 nm. Cell survival fractions were calculated as a percentage of the untreated control. In addition, IC 50 values were derived from the concentration-response curves.
Modulation of IL-2 production assay:
The IL-2 release study was conducted using Jurkat cells (E6-1 clone), a leukemic T-cell line known to produce IL-2 upon mitogen stimulation [11] . Jurkat E6-1 cells were seeded in 24 well microplates (10 6 cells/well), in triplicate, stimulated with 20 ng/mL 12-O-tetradecanoylphorbol 13acetate (PMA) and 10 µg/mL phytohemaglutinin (PHA) for IL-2 release and incubated either in the presence of test compounds 1-4 (at 25 µM) or the solvent DMSO for 24 h. The cultured supernatants were obtained and the concentration of the released IL-2 was directly determined by a commercially available ELISA kit (Diaclone, USA), according to the instructions of the manufacturer and quantified as ng/mL using a freshly prepared standard curve. The results were evaluated as percentage stimulation and interpreted as previously described [12] . Stimulation between 70 and 100% was considered high, between 40 and 69% moderate, and between 20 and 39% low.
